PCG
CYCLIC GUANOSINE MONOPHOSPHATE
Created: | 1999-07-08 |
Last modified: | 2024-09-27 |
Find Related PDB Entry |
---|
Find related ligands: |
---|
Chemical Details | |
---|---|
Formal Charge | 0 |
Atom Count | 35 |
Chiral Atom Count | 5 |
Bond Count | 38 |
Aromatic Bond Count | 5 |
Chemical Component Summary | |
---|---|
Name | CYCLIC GUANOSINE MONOPHOSPHATE |
Systematic Name (OpenEye OEToolkits) | 2-amino-9-[(4R,6S,7R,8R)-4,7-dihydroxy-4-oxo-3,5,9-trioxa-4$l^{5}-phosphabicyclo[4.3.0]nonan-8-yl]-1H-purin-6-one |
Formula | C10 H12 N5 O7 P |
Molecular Weight | 345.205 |
Type | NON-POLYMER |
Chemical Descriptors | |||
---|---|---|---|
Type | Program | Version | Descriptor |
SMILES | ACDLabs | 10.04 | O=C4NC(=Nc1c4ncn1C3OC2COP(=O)(OC2C3O)O)N |
SMILES | CACTVS | 3.341 | NC1=Nc2n(cnc2C(=O)N1)[CH]3O[CH]4CO[P](O)(=O)O[CH]4[CH]3O |
SMILES | OpenEye OEToolkits | 1.5.0 | c1nc2c(n1C3C(C4C(O3)COP(=O)(O4)O)O)N=C(NC2=O)N |
Canonical SMILES | CACTVS | 3.341 | NC1=Nc2n(cnc2C(=O)N1)[C@@H]3O[C@@H]4CO[P@](O)(=O)O[C@H]4[C@H]3O |
Canonical SMILES | OpenEye OEToolkits | 1.5.0 | c1nc2c(n1[C@H]3[C@@H]([C@H]4C(O3)CO[P@](=O)(O4)O)O)N=C(NC2=O)N |
InChI | InChI | 1.03 | InChI=1S/C10H12N5O7P/c11-10-13-7-4(8(17)14-10)12-2-15(7)9-5(16)6-3(21-9)1-20-23(18,19)22-6/h2-3,5-6,9,16H,1H2,(H,18,19)(H3,11,13,14,17)/t3-,5-,6-,9-/m1/s1 |
InChIKey | InChI | 1.03 | ZOOGRGPOEVQQDX-UUOKFMHZSA-N |
Drug Info: DrugBank
DrugBank ID | DB02315 |
---|---|
Name | Cyclic GMP |
Groups | experimental |
Description | Cyclic guanosine monophosphate (Cyclic GMP) is a guanine nucleotide containing one phosphate group which is esterified to the sugar moiety in both the 3'- and 5'-positions. It is a cellular regulatory agent and has been described as a second messenger. Its levels increase in response to a variety of hormones, including acetylcholine, insulin, and oxytocin and it has been found to activate specific protein kinases. (From Merck Index, 11th ed) |
Synonyms |
|
Categories |
|
CAS number | 7665-99-8 |
Drug Targets
Name | Target Sequence | Pharmacological Action | Actions |
---|---|---|---|
cGMP-dependent 3',5'-cyclic phosphodiesterase | MGQACGHSILCRSQQYPAARPAEPRGQQVFLKPDEPPPPPQPCADSLQDA... | unknown | |
Potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 2 | MDARGGGGRPGESPGATPAPGPPPPPPPAPPQQQPPPPPPPAPPPGPGPA... | unknown | |
cAMP-dependent protein kinase type I-alpha regulatory subunit | MESGSTAASEEARSLRECELYVQKHNIQALLKDSIVQLCTARPERPMAFL... | unknown | |
Solute carrier family 22 member 6 | MAFNDLLQQVGGVGRFQQIQVTLVVLPLLLMASHNTLQNFTAAIPTHHCR... | unknown |
Drug Info/Drug Targets: DrugBank 3.0: a comprehensive resource for 'omics' research on drugs. Knox C, Law V, Jewison
T, Liu P, Ly S, Frolkis A, Pon A, Banco K, Mak C, Neveu V, Djoumbou Y, Eisner R, Guo AC, Wishart DS.
Nucleic Acids Res. 2011 Jan; 39 (Database issue):D1035-41. | PMID:21059682
Related Resource References
Resource Name | Reference |
---|---|
PubChem | 24316, 5280386, 135398570 |
ChEMBL | CHEMBL395336 |
ChEBI | CHEBI:16356 |